Raras
Buscar doenças, sintomas, genes...
Discinesia paroxística cinesigênica
ORPHA:98809CID-10 · G24.8CID-11 · 8A02.2DOENÇA RARA

A discinesia cinesigênica paroxística (PKD) é uma forma de discinesia paroxística, caracterizada por hipercinesias involuntárias breves e recorrentes, como coreoatetose, balismo, atetose ou distonia, desencadeadas por movimentos bruscos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A discinesia cinesigênica paroxística (PKD) é uma forma de discinesia paroxística, caracterizada por hipercinesias involuntárias breves e recorrentes, como coreoatetose, balismo, atetose ou distonia, desencadeadas por movimentos bruscos.

Pesquisas ativas
2 ensaios
6 total registrados no ClinicalTrials.gov
Publicações científicas
409 artigos
Último publicado: 2026 Mar 2

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.6
Worldwide
Início
Adolescent
+ adult, childhood, infancy
🏥
SUS: Cobertura mínimaScore: 20%
Triagem neonatal (Fase 5)CID-10: G24.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
3 sintomas
💪
Músculos
3 sintomas
🧠
Neurológico
2 sintomas

+ 8 sintomas em outras categorias

Características mais comuns

90%prev.
Atetose
Muito frequente (99-80%)
90%prev.
Coreia
Muito frequente (99-80%)
90%prev.
Discinesia
Muito frequente (99-80%)
90%prev.
Movimentos involuntários
Muito frequente (99-80%)
90%prev.
Distonia
Muito frequente (99-80%)
55%prev.
Crise sensorial focal
Frequente (79-30%)
16sintomas
Muito frequente (5)
Frequente (1)
Ocasional (3)
Sem dados (7)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 16 características clínicas mais associadas, ordenadas por frequência.

AtetoseAthetosis
Muito frequente (99-80%)90%
CoreiaChorea
Muito frequente (99-80%)90%
DiscinesiaDyskinesia
Muito frequente (99-80%)90%
Movimentos involuntáriosInvoluntary movements
Muito frequente (99-80%)90%
DistoniaDystonia
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico409PubMed
Últimos 10 anos200publicações
Pico202135 papers
Linha do tempo
2026Hoje · 2026🧪 1996Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: qPCR para deleção de SMN1 em sangue seco
Fase 5 do PNTNpending
Incidência no Brasil: 1:10.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

4 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

PRRT2Proline-rich transmembrane protein 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

As a component of the outer core of AMPAR complex, may be involved in synaptic transmission in the central nervous system. In hippocampal neurons, in presynaptic terminals, plays an important role in the final steps of neurotransmitter release, possibly by regulating Ca(2+)-sensing. In the cerebellum, may inhibit SNARE complex formation and down-regulate short-term facilitation

LOCALIZAÇÃO

Cell membranePresynaptic cell membraneSynapseCell projection, axonCytoplasmic vesicle, secretory vesicle, synaptic vesicle membranePostsynaptic density membraneCell projection, dendritic spine

MECANISMO DE DOENÇA

Episodic kinesigenic dyskinesia 1

An autosomal dominant form of paroxysmal kinesigenic dyskinesia, a neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
606.4 TPM
Cérebro - Hemisfério cerebelar
563.4 TPM
Ovário
183.2 TPM
Brain Frontal Cortex BA9
167.2 TPM
Córtex cerebral
152.5 TPM
OUTRAS DOENÇAS (9)
episodic kinesigenic dyskinesia 1seizures, benign familial infantile, 2infantile convulsions and choreoathetosisfamilial or sporadic hemiplegic migraine
HGNC:30500UniProt:Q7Z6L0
KCNJ10ATP-sensitive inward rectifier potassium channel 10Disease-causing germline mutation(s) inModerado
FUNÇÃO

May be responsible for potassium buffering action of glial cells in the brain (By similarity). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:8995301). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:8995301). The inward rectification is mainly d

LOCALIZAÇÃO

MembraneBasolateral cell membrane

VIAS BIOLÓGICAS (3)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunitsPotassium transport channels
MECANISMO DE DOENÇA

Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance

A complex disorder characterized by generalized seizures with onset in infancy, delayed psychomotor development, ataxia, sensorineural hearing loss, hypokalemia, metabolic alkalosis, and hypomagnesemia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
132.0 TPM
Brain Caudate basal ganglia
61.6 TPM
Substância negra
60.1 TPM
Brain Putamen basal ganglia
56.0 TPM
Córtex cerebral
49.6 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 4EAST syndromePendred syndromeepisodic kinesigenic dyskinesia
HGNC:6256UniProt:P78508
KCNA1Potassium voltage-gated channel subfamily A member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the kidney (PubMed:19903818, PubMed:8845167). Contributes to the regulation of the membrane potential and nerve signaling, and prevents neuronal hyperexcitability (PubMed:17156368). Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alte

LOCALIZAÇÃO

Cell membraneMembraneCell projection, axonCytoplasmic vesiclePerikaryonEndoplasmic reticulumCell projection, dendriteCell junctionSynapsePresynaptic cell membranePresynapse

VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Episodic ataxia 1

An autosomal dominant disorder characterized by brief episodes of ataxia and dysarthria. Neurological examination during and between the attacks demonstrates spontaneous, repetitive discharges in the distal musculature (myokymia) that arise from peripheral nerve. Nystagmus is absent.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
56.0 TPM
Cerebelo
42.4 TPM
Brain Frontal Cortex BA9
13.3 TPM
Brain Nucleus accumbens basal ganglia
7.8 TPM
Brain Caudate basal ganglia
7.8 TPM
OUTRAS DOENÇAS (5)
episodic ataxia type 1early-infantile DEEepisodic kinesigenic dyskinesiahereditary continuous muscle fiber activity
HGNC:6218UniProt:Q09470
TMEM151ATransmembrane protein 151ADisease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Endoplasmic reticulum membraneCell projection, axonCell projection, dendrite

MECANISMO DE DOENÇA

Episodic kinesigenic dyskinesia 3

A form of paroxysmal kinesigenic dyskinesia, a neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements. These attacks can involve dystonic postures, chorea, or athetosis. EKD3 is an autosomal dominant form with incomplete penetrance and onset in late childhood or early adolescence. Symptoms are usually triggered by sudden movement or stress, and resolve in most patients in their early twenties or later.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
180.9 TPM
Brain Frontal Cortex BA9
55.3 TPM
Córtex cerebral
55.0 TPM
Hipocampo
54.3 TPM
Substância negra
51.5 TPM
OUTRAS DOENÇAS (1)
episodic kinesigenic dyskinesia 3
HGNC:HGNC:28497UniProt:Q8N4L1

Variantes genéticas (ClinVar)

294 variantes patogênicas registradas no ClinVar.

🧬 TMEM151A: NM_153266.4(TMEM151A):c.877G>T (p.Ala293Ser) ()
🧬 TMEM151A: NM_153266.4(TMEM151A):c.391G>T (p.Asp131Tyr) ()
🧬 TMEM151A: NM_153266.4(TMEM151A):c.827C>T (p.Pro276Leu) ()
🧬 TMEM151A: NM_153266.4(TMEM151A):c.305del (p.Pro102fs) ()
🧬 TMEM151A: GRCh37/hg19 11q12.1-13.3(chr11:56895955-69295402)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1 variantes classificadas pelo ClinVar.

1
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
NBEA: NM_001385012.1(NBEA):c.8659C>T (p.Arg2887Trp) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Discinesia paroxística cinesigênica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
250 papers (10 anos)
#1

A Case of Atypical Presentation of Paroxysmal Movement Disorder, Contributed to PRRT2 Gene Variant.

Journal of child neurology2026 Feb 09

The PRRT2 gene located at 16p11 encodes proline-rich transmembrane protein with the heterozygous PRRT2 mutation being commonly reported. The most common variant found was the c.649dup.(Arg217Profs*8). Various case reviews documenting pathogenic PRRT2 variants reported an association with paroxysmal movement disorders, including paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy, paroxysmal kinesigenic dyskinesia associated with infantile convulsions (PKD/IC), also known as infantile convulsions with choreoathetosis syndrome paroxysmal non-kinesigenic dyskinesia (PNKD), hemiplegic migraine, and exercise-induced dyskinesia. However, more recent reports have also documented mutation associated with a broader clinical picture presenting with congenital microcephaly, severe learning difficulties, and pharmacoresistant encephalopathy. We hereby report a patient who presented with paroxysmal dyskinesia, harbouring the mutation variant on PRRT2 gene. At 5 months of age, our proband presented to emergency because of jerking movements while in a moving car. This was followed by generalized tonic-clonic seizures and kinesigenic posturing. The latter would occur tens of times per day and a specific trigger did not always prevail. The movements responded well to low-dose carbamazepine and genetic studies confirmed a mutated variant of c.649dup.(Arg217Profs*8).

#2

Heterozygous Loss-of-Function Variants of KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia.

Movement disorders : official journal of the Movement Disorder Society2026 Mar 02

Heterozygous variants of potassium inwardly rectifying channel subfamily J member 10 (KCNJ10) were previously reported to be enriched in several patients with paroxysmal kinesigenic dyskinesia (PKD). The aim was to confirm the pathogenesis of KCNJ10 variants and the relationship between KCNJ10 variants and PKD phenotypes. The whole-exome sequencing followed by Sanger sequencing were used to screen the potential pathogenic KCNJ10 variants in a cohort of PKD patients. Functional studies were performed to check the pathogenicity of the variants. The clinical characteristics of KCNJ10-related PKD patients reported to date were reviewed. Five heterozygous KCNJ10 variants including c.76C>T (p.R26*), c.436C>T (p.L146F), c.484A>G (p.T162A), c.524G>A (p.R175Q), and c.923del (p.G308Afs*17), were detected in five pedigrees and three sporadic patients. All variants had extremely low frequency in normal populations and were highly conserved between species. They influenced the location or expression of potassium inwardly rectifying channel (Kir) 4.1 and resulted in the Kir currents of cell decreased to varied degrees. Up to date, 31 KCNJ10 variants had been reported to manifest as PKD, and a significant majority (22/31, 71%) were in the cytoplasmic domain near the C-terminus. Notably, the KCNJ10-related PKD patients showed a pronounced male predominance. The study confirmed the correlation between PKD and the loss-of-function of Kir4.1 resulted from heterozygous KCNJ10 variants. The distribution bias of PKD-related KCNJ10 variants as well as the male predominance in affected individuals shed light on the mechanism investigation of this subtype of PKD. © 2026 International Parkinson and Movement Disorder Society.

#3

Motor-planning cerebello-cerebral network alterations in PRRT2-related paroxysmal kinesigenic dyskinesia.

Parkinsonism &amp; related disorders2026 Mar

Emerging preclinical evidence suggests that the cerebellum plays a critical role in paroxysmal kinesigenic dyskinesia (PKD) associated with proline-rich transmembrane protein 2 (PRRT2) mutations. This study aimed to investigate the role of cerebello-cerebral network in PKD patients with PRRT2 mutations (PKD-M) and PKD patients with no PRRT2 mutations (PKD-N). Resting-state functional magnetic resonance imaging scan was performed on 105 PKD patients (47 PKD-M and 58 PKD-N) and 62 healthy controls (HC). For seed-based functional connectivity (FC) analysis, the cerebellum was parcellated into 10 function-related regions through a functional atlas of the human cerebellum obtained by a multi-domain task battery. The cerebello-cerebral FC and regional homogeneity (ReHo) were examined using one-way analysis of covariance and two-sample t-test in PKD-M, PKD-N and HC. PKD-M had increased FC between a motor-planning related cerebellar region (region 4) and the middle cingulate gyrus, compared to HC. While PKD-M had decreased FC between this region and the lingual gyrus, compared to HC. PKD-M had increased FC between another cerebellar region (region 8) and the right inferior temporal gyrus/right superior frontal gyrus, compared to PKD-N. Additionally, PKD-M had decreased ReHo in the pons and the cerebellum anterior lobe and increased ReHo in the right inferior temporal gyrus, compared to HC. PRRT2 mutations may cause abnormalities in a motor-planning cerebello-cerebral network, which likely play a major role in the pathogenesis of PKD-M.

#4

Clinical and Genetic Characteristics of Paroxysmal Kinesigenic Dyskinesia: A Single-Center Study and Literature Review.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology2026 Jan 31

Paroxysmal kinesigenic dyskinesia (PKD) is a genetically heterogeneous movement disorder primarily associated with PRRT2 variants. Recently, TMEM151A and KCNJ10 have emerged as additional PKD-associated genes. However, genotype-phenotype correlations remain poorly defined. In this study, we retrospectively analyzed 41 PKD patients from a single center in Southeastern China. All patients underwent comprehensive clinical evaluation and whole-exome sequencing (WES), with variant classification based on ACMG guidelines. Additionally, we conducted a literature review of PKD cohorts published since 2021 to compare the clinical characteristics of patients carrying PRRT2, TMEM151A, KCNJ10 variants, and those without identified mutations. A genetic diagnosis was achieved in 19/41 patients (46.3%), with PRRT2 being the most frequent. We identified five novel variants, including two in KCNJ10, two in TMEM151A, and one in PNKD. Compared to other groups, PRRT2-positive patients had the earliest onset and highest treatment response. TMEM151A-positive patients tended to exhibit more frequent attacks and a lower response to carbamazepine. KCNJ10-positive patients presented with later onset and ultra-brief attacks. Genetically negative cases displayed distinct features, including fewer auras and more unilateral, ultra-brief episodes, yet responded well to carbamazepine. PKD exhibits significant genotype-dependent clinical heterogeneity. Novel variants in TMEM151A and KCNJ10 expand the mutational spectrum and suggest emerging genotype-specific phenotypic trends. Systematic genetic and phenotypic profiling may guide more precise diagnosis and management of PKD.

#5

Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion: A Case Report.

Case reports in neurology2025

Paroxysmal kinesigenic dyskinesia (PKD) is a rare movement disorder which can present a diagnostic challenge. We present a case with video examples, of an uncommon cause of PKD. A 16-year-old male presented with abrupt onset, brief episodes of right-sided head version, usually accompanied by extension of the left and rarely right arm. He experienced preceding bilateral sensory disturbance in his legs. His twin brother was diagnosed with focal seizures. There were no neurodevelopmental concerns. Sudden movement preceded stereotypical episodes. MRI brain was unremarkable. Home video and video EEG were utilised to reach a clinical diagnosis. The clinical phenotype of PKD was recognised, and he was treated with low-dose carbamazepine. Next-generation sequencing showed no pathogenic variant in gene panels for dystonia or channelopathies, including the common genes associated with PKD such as PRRT2 mutations. Subsequent microarray testing demonstrated a pathogenic 599 kb gene deletion on the 16p11.2 region, which includes the PRRT2 gene, confirming the diagnosis of PKD. PKD is an important diagnosis to consider due to the potential delay in diagnosis, genetic implications, and treatment responsiveness. Video recordings are valuable diagnostic tools. When suspecting PKD, screening for PRRT2 variants as well as 16p11.2 microdeletions should be considered.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC253 artigos no totalmostrando 194

2026

Heterozygous Loss-of-Function Variants of KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia.

Movement disorders : official journal of the Movement Disorder Society
2026

A Case of Atypical Presentation of Paroxysmal Movement Disorder, Contributed to PRRT2 Gene Variant.

Journal of child neurology
2026

Motor-planning cerebello-cerebral network alterations in PRRT2-related paroxysmal kinesigenic dyskinesia.

Parkinsonism &amp; related disorders
2026

Clinical and Genetic Characteristics of Paroxysmal Kinesigenic Dyskinesia: A Single-Center Study and Literature Review.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion: A Case Report.

Case reports in neurology
2025

Multiple phenotypic traits including developmental impairment in a Chinese family with infantile convulsion and choreoathetosis syndrome: a case study expanding the clinical spectrum of prrt2-related syndrome.

BMC pediatrics
2025

Functional Characterization and Pathogenicity Classification of PRRT2 Splice Variants in PRRT2-Related Disorders.

Annals of clinical and translational neurology
2025

TMEM151A-related Paroxysmal Kinesigenic Dyskinesia in first two Indian families.

Parkinsonism &amp; related disorders
2025

Paroxysmal Kinesigenic Dyskinesia With Infantile Convulsions in a Child With Inherited Co-deletion of 16p11.2 and 16p12.2: A Case Report and Literature Review.

Cureus
2025

Transient Dysarthria and Hemiparesis in an Adolescent.

European journal of case reports in internal medicine
2025

Paroxysmal Kinesigenic Dyskinesia - A Case Series of 20 Children From North India.

Neurology India
2025

Faciobrachial dystonic seizure can be triggered by swallowing in LGI1 encephalitis.

BMC neurology
2025

Beyond seizures: The genetic mystery of paroxysmal kinesigenic dyskinesia.

Epileptic disorders : international epilepsy journal with videotape
2025

[Clinical phenotypic and genetic analysis of three children with Paroxysmal kinesigenic dyskinesia and Self-limited familial infantile epilepsy caused by PRRT2 gene mutation].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Paroxysmal Kinesigenic Dyskinesia in Two Siblings With Novel Heterozygous TMEM151A Frameshift Variant: The First Case Report in Japan.

American journal of medical genetics. Part A
2025

Genotypic and phenotypic characteristics of ADGRV1 mutations in four children and functional validation in a zebrafish model.

Gene
2025

Proprioceptive-Induced Reflex Seizure Mimicking Paroxysmal Kinesigenic Dyskinesia in Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.

Journal of clinical neurology (Seoul, Korea)
2025

Deep Learning Recognition of Paroxysmal Kinesigenic Dyskinesia Based on EEG Functional Connectivity.

International journal of neural systems
2024

Unilateral hemichorea and hemiballismus in a woman in her late 70s.

BMJ case reports
2024

Unraveling the Membrane Topology of TMEM151A: A Step Towards Understanding its Cellular Role.

Journal of molecular biology
2024

Heterozygous KCNJ10 Variants Affecting Kir4.1 Channel Cause Paroxysmal Kinesigenic Dyskinesia.

Movement disorders : official journal of the Movement Disorder Society
2024

Gray matter structural alterations of cortico-striato-thalamo-cortical loop in familial Paroxysmal Kinesigenic Dyskinesia.

Heliyon
2024

Potassium Channel Subunit Kir4.1 Mutated in Paroxysmal Kinesigenic Dyskinesia: Screening of an Italian Cohort.

Movement disorders : official journal of the Movement Disorder Society
2024

Proline-rich transmembrane protein 2 regulates the magnitude and frequency of dopamine release by repetitive neuronal stimuli in the striatum of L-dopa-treated mice.

Neuropsychopharmacology reports
2024

Paroxysmal movement disorders.

Handbook of clinical neurology
2024

Canine paroxysmal dyskinesia-a review.

Frontiers in veterinary science
2024

Three siblings with self-limited familial infantile epilepsy with PRRT2 mutation: A case series.

SAGE open medical case reports
2024

Pseudohypoparathyroidism type 1B with involuntary movements: a case report and literature review.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2024

Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency.

Annals of neurology
2025

Evaluating the Performance of In Silico Tools for PRRT2 Missense Variants.

Combinatorial chemistry &amp; high throughput screening
2024

A new genetic diagnosis strategy for paroxysmal kinesigenic dyskinesia: Targeted high-throughput detection of PRRT2 gene c.649 locus.

Molecular genetics &amp; genomic medicine
2024

Identification of a de novo CACNA1B variant and a start-loss ADRA2B variant in paroxysmal kinesigenic dyskinesia.

Heliyon
2024

Both gain- and loss-of-function variants of KCNA1 are associated with paroxysmal kinesigenic dyskinesia.

Journal of genetics and genomics = Yi chuan xue bao
2024

Long-term low-dose lamotrigine for paroxysmal kinesigenic dyskinesia: a two-year investigation of cognitive function in children.

Frontiers in psychiatry
2024

Misdiagnosis of functional neurological symptom disorders in paediatrics: Narrative review and relevant case report.

Clinical child psychology and psychiatry
2024

Dopa-responsive dystonia and paroxysmal dystonic attacks associated with ATP1A3 gene variant.

Practical neurology
2024

Emergence of lingual dystonia and strabismus in early-onset SCN8A self-limiting familial infantile epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2024

Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic Dyskinesia.

Movement disorders : official journal of the Movement Disorder Society
2024

A Girl with PRRT2 Mutation Presenting with Benign Familial Infantile Seizures Followed by Autistic Regression.

Case reports in pediatrics
2024

Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia.

Therapeutic advances in neurological disorders
2024

An Electroencephalography Profile of Paroxysmal Kinesigenic Dyskinesia.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024

Paroxysmal Kinesigenic Dyskinesia: Genetics and Pathophysiological Mechanisms.

Neuroscience bulletin
2024

Effects of PRRT2 mutation on brain gray matter networks in paroxysmal kinesigenic dyskinesia.

Cerebral cortex (New York, N.Y. : 1991)
2023

[A case of a pathological variant of the PRRT2 gene in twins with paroxysmal kinesiogenic dyskinesia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2023

Proline-rich transmembrane protein 2 knock-in mice present dopamine-dependent motor deficits.

Journal of biochemistry
2023

Associated movement disorder as a clue for the diagnosis of paroxysmal kinesigenic dyskinesia in a child with focal epilepsy.

Journal of neurosciences in rural practice
2023

Functional Neurological Disorder Overlapping Paroxysmal Kinesigenic Dyskinesia Confirmed by Genetic Diagnosis.

Cureus
2023

Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia.

Handbook of clinical neurology
2023

A Curious Case of a Child With Recurrent Twisting Movements of Limbs.

Cureus
2023

Evaluation of iron deposition in the motor CSTC loop of a Chinese family with paroxysmal kinesigenic dyskinesia using quantitative susceptibility mapping.

Frontiers in neurology
2023

Non-Motor Symptoms and Quality of Life in Patients with PRRT2-Related Paroxysmal Kinesigenic Dyskinesia.

Movement disorders clinical practice
2023

Genetic Movement Disorders Commonly Seen in Asians.

Movement disorders clinical practice
2023

Nine Hereditary Movement Disorders First Described in Asia: Their History and Evolution.

Journal of movement disorders
2023

Translating Genetic Discovery into a Mechanistic Understanding of Pediatric Movement Disorders: Lessons from Genetic Dystonias and Related Disorders.

Advanced genetics (Hoboken, N.J.)
2023

Missense mutations in the membrane domain of PRRT2 affect its interaction with Nav1.2 voltage-gated sodium channels.

Neurobiology of disease
2023

Low-intensity ultrasound directly modulates neural activity of the cerebellar cortex.

Brain stimulation
2023

Peri-ictal EEG in infants with PRRT2-related self-limited infantile epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2023

TMEM151A variants associated with paroxysmal kinesigenic dyskinesia.

Human genetics
2023

Novel missense variant in the TMEM151A gene causing paroxysmal kinesigenic dyskinesia: a case report with literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

TMEM151A as an alternative to PRRT2 in paroxysmal kinesigenic dyskinesia: About three new cases.

Parkinsonism &amp; related disorders
2023

The Pathogenesis of Paroxysmal Kinesigenic Dyskinesia: Current Concepts.

Movement disorders : official journal of the Movement Disorder Society
2023

A novel SLC20A2 mutation presenting with paroxysmal kinesigenic dyskinesia and epilepsy in a Chinese patient: a case report.

Acta neurologica Belgica
2022

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases.

Frontiers in pediatrics
2023

A Push-Pull Mechanism Between PRRT2 and β4-subunit Differentially Regulates Membrane Exposure and Biophysical Properties of NaV1.2 Sodium Channels.

Molecular neurobiology
2022

Elderly-Onset Paroxysmal Kinesigenic Dyskinesia: A Case Report.

Neurology and therapy
2022

PRRT2 gene mutations associated with infantile convulsions induced by sucking and the genotype-phenotype correlation.

Frontiers in neurology
2022

Multiple Sclerosis-Related Paroxysmal Kinesigenic Dyskinesia: Long Term, Favorable Response to Lacosamide.

Journal of movement disorders
2022

TMEM151A phenotypic spectrum includes paroxysmal kinesigenic dyskinesia with infantile convulsions.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

PRRT2 mutation in a Japanese woman: Adult-onset focal epilepsy coexisting with movement disorders and cerebellar atrophy.

Epilepsy &amp; behavior reports
2022

Screening of the TMEM151A Gene in Patients With Paroxysmal Kinesigenic Dyskinesia and Other Movement Disorders.

Frontiers in neurology
2022

Haploinsufficiency of PRRT2 Leading to Familial Hemiplegic Migraine in Chromosome 16p11.2 Deletion Syndrome.

Neuropediatrics
2022

De Novo Mutation in TMEM151A and Paroxysmal Kinesigenic Dyskinesia.

Movement disorders : official journal of the Movement Disorder Society
2022

Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study.

Parkinsonism &amp; related disorders
2022

PRRT2 Mutation and Serum Cytokines in Paroxysmal Kinesigenic Dyskinesia.

Current medical science
2022

Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia.

Journal of neurology
2022

Paroxysmal Kinesigenic Dyskinesia Secondary to Pseudohypoparathyroidism Responding to Correction of Calcium.

Movement disorders clinical practice
2022

A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.

Brain &amp; development
2022

A novel domain within the CIL regulates egress of IFITM3 from the Golgi and reveals a regulatory role of IFITM3 on the secretory pathway.

Life science alliance
2022

Characteristics of infantile convulsions and choreoathetosis syndrome caused by PRRT2 mutation.

Pediatric investigation
2022

Paroxysmal Kinesigenic Dyskinesia Masquerading as Dissociative Disorder: A Case Report on Pseudo-Dissociation.

Neurology India
2022

Paroxysmal Non-Kinesigenic Choreoathetosis Case Report and a Review of the Pathogenesis.

Cureus
2022

Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion and Related Clinical Features.

Neurology. Genetics
2022

Case Report: A Case of Concomitant Paroxysmal Kinesigenic Dyskinesia and Epilepsy: Can We Treat Two Birds With One Stone?

Frontiers in neurology
2022

Features Differ Between Paroxysmal Kinesigenic Dyskinesia Patients with PRRT2 and TMEM151A Variants.

Movement disorders : official journal of the Movement Disorder Society
2022

Cerebellum Dysfunction in Patients With PRRT2-Related Paroxysmal Dyskinesia.

Neurology
2022

PRRT2- Associated Paroxysmal Kinesigenic Dyskinesia Only Evident with High-Speed Cricket Bowling.

Movement disorders clinical practice
2022

Exome-Wide Analyses in Paroxysmal Kinesigenic Dyskinesia Confirm TMEM151A as a Novel Causative Gene.

Movement disorders : official journal of the Movement Disorder Society
2021

Case Report: Long-Term Suppression of Paroxysmal Kinesigenic Dyskinesia After Bilateral Thalamotomy.

Frontiers in neurology
2022

Secondary Paroxysmal Kinesigenic Dyskinesia with a CASR Mutation.

Movement disorders : official journal of the Movement Disorder Society
2021

Penetrance estimation of PRRT2 variants in paroxysmal kinesigenic dyskinesia and infantile convulsions.

Frontiers of medicine
2022

TMEM151A Variants Cause Paroxysmal Kinesigenic Dyskinesia: A Large-Sample Study.

Movement disorders : official journal of the Movement Disorder Society
2022

Paroxysmal Kinesigenic Dyskinesia Secondary to Brain Calcification with a Homozygous MYORG Mutation.

Movement disorders : official journal of the Movement Disorder Society
2021

A heterozygous deletion of PDGFB gene causes paroxysmal kinesigenic dyskinesia with primary familial brain calcification.

Parkinsonism &amp; related disorders
2021

Author Correction: TMEM151A variants cause paroxysmal kinesigenic dyskinesia.

Cell discovery
2021

Successful Treatment of a Paroxysmal Kinesigenic Dyskinesia Patient with Carbamazepine-Induced Stevens-Johnson Syndrome Using Oxcarbazepine Monotherapy: A Case Report.

Case reports in neurology
2021

An Emerging Role of PRRT2 in Regulating Growth Cone Morphology.

Cells
2022

Hemiplegic Migraine Associated With PRRT2 Variations: A Clinical and Genetic Study.

Neurology
2021

Carbamazepine-Responsive Chorea in a Toddler with Semilobar Holoprosencephaly: Case Report.

Journal of pediatric neurosciences
2021

Cerebellar spreading depolarization mediates paroxysmal movement disorder.

Cell reports
2021

TMEM151A variants cause paroxysmal kinesigenic dyskinesia.

Cell discovery
2021

Expanding the phenotypic spectrum of pathogenic variants in the PRRT2 gene: bilateral papilledema and abducens nerve palsies secondary to pseudotumor cerebri syndrome.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2021

PRRT2 Gene Mutations in Indian Paroxysmal Kinesigenic Dyskinesia Patients.

Annals of Indian Academy of Neurology
2021

Novel Mutation in CACNA1A Associated with Activity-Induced Dystonia, Cervical Dystonia, and Mild Ataxia.

Case reports in neurological medicine
2022

Phenotypic characterisation of paroxysmal dyskinesia in Sphynx cats.

Journal of feline medicine and surgery
2021

Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Frontiers in neurology
2021

A case of paroxysmal kinesigenic dyskinesia suspected to be reflex epilepsy.

Nagoya journal of medical science
2021

Age-dependent neurological phenotypes in a mouse model of PRRT2-related diseases.

Neurogenetics
2021

The Genotype and Phenotype of Proline-Rich Transmembrane Protein 2 Associated Disorders in Chinese Children.

Frontiers in pediatrics
2021

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Probably Caused by DSG2 p.Val149Ile Mutation as Genetic Background When Carrying with Heterozygous PRRT2 p.Arg217ProfsTer8 Mutation: A Case Report.

International medical case reports journal
2021

Paroxysmal Kinesigenic Dyskinesia in Twins With Chromosome 16p11.2 Duplication Syndrome.

Neurology. Genetics
2021

Beyond the AMPA receptor: Diverse roles of SynDIG/PRRT brain-specific transmembrane proteins at excitatory synapses.

Current opinion in pharmacology
2021

Paroxysmal Genetic Movement Disorders and Epilepsy.

Frontiers in neurology
2021

Novel PRRT2 gene variants identified in paroxysmal kinesigenic dyskinesia and benign familial infantile epilepsy in Chinese families.

Experimental and therapeutic medicine
2021

The Spectrum of PRRT2-Associated Disorders: Update on Clinical Features and Pathophysiology.

Frontiers in neurology
2021

An interaction between PRRT2 and Na+/K+ ATPase contributes to the control of neuronal excitability.

Cell death &amp; disease
2021

Familial paroxysmal kinesigenic dyskinesia with a novel missense variant (Arg2866Trp) in NBEA.

Journal of human genetics
2021

Exercise test for patients with new-onset paroxysmal kinesigenic dyskinesia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.

Translational neurodegeneration
2021

Generation of an induced pluripotent stem cell line (ZZUi022-A) from a paroxysmal kinesigenic dyskinesia individual carrying the PRRT2 gene mutation.

Stem cell research
2021

Paroxysmal kinesigenic dyskinesia: a diagnostic challenge.

BMJ case reports
2021

Paroxysmal kinesigenic dyskinesia associated with a novel POLG variant: A case report.

Medicine
2021

Increased responsiveness at the cerebellar input stage in the PRRT2 knockout model of paroxysmal kinesigenic dyskinesia.

Neurobiology of disease
2021

Biallelic XPR1 mutation associated with primary familial brain calcification presenting as paroxysmal kinesigenic dyskinesia with infantile convulsions.

Brain &amp; development
2020

A Child Who Suddenly Freezes While Trying to Cross Crosswalks-Unique Clinical Manifestation of Paroxysmal Kinesigenic Dyskinesia: A Case Report.

Children (Basel, Switzerland)
2021

Neural Mechanisms of Paroxysmal Kinesigenic Dyskinesia: Insights from Neuroimaging.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2020

The Phenotypic Spectrum of PRRT2-Associated Paroxysmal Neurologic Disorders in Childhood.

Biomedicines
2021

Disruption of gray matter morphological networks in patients with paroxysmal kinesigenic dyskinesia.

Human brain mapping
2020

Proline-rich transmembrane protein 2 (PRRT2) regulates the actin cytoskeleton during synaptogenesis.

Cell death &amp; disease
2020

Severe Choreo-Ballism Episodes Due to PRRT2 Gene Mutations-A Vignette.

Movement disorders clinical practice
2020

Zonisamide Therapy for Patients With Paroxysmal Kinesigenic Dyskinesia.

Pediatric neurology
2020

Presynaptic PRRT2 Deficiency Causes Cerebellar Dysfunction and Paroxysmal Kinesigenic Dyskinesia.

Neuroscience
2020

A Japanese family with primary familial brain calcification presenting with paroxysmal kinesigenic dyskinesia - A comprehensive mutational analysis.

Journal of the neurological sciences
2020

Paroxysmal dyskinesia and epilepsy in pseudohypoparathyroidism.

Molecular genetics &amp; genomic medicine
2020

Clinical spectrum and genotype-phenotype correlations in PRRT2 Italian patients.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2020

Brain structural connectome in relation to PRRT2 mutations in paroxysmal kinesigenic dyskinesia.

Human brain mapping
2020

A Novel PRRT2 Variant in Chinese Patients Suffering from Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsion.

Behavioural neurology
2020

Lacosamide for children with paroxysmal kinesigenic dyskinesia.

Brain &amp; development
2020

The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China.

Movement disorders : official journal of the Movement Disorder Society
2020

Novel mutation of the PRRT2 gene in two cases of paroxysmal kinesigenic dyskinesia: Two case reports.

Biomedical reports
2020

Primary brain calcification due to a homozygous MYORG mutation causing isolated paroxysmal kinesigenic dyskinesia.

Brain : a journal of neurology
2020

Treatment of Paroxysmal Dyskinesia.

Neurologic clinics
2020

Different experiences of two PRRT2-associated self-limited familial infantile epilepsy.

Acta neurologica Belgica
2020

Corrigendum to "PRRT2 frameshift mutation reduces its mRNA stability resulting loss of function in paroxysmal kinesigenic dyskinesia".

Biochemical and biophysical research communications
2020

Altered topological organization of functional brain networks in drug-naive patients with paroxysmal kinesigenic dyskinesia.

Journal of the neurological sciences
2020

Complicated paroxysmal kinesigenic dyskinesia associated with SACS mutations.

Annals of translational medicine
2019

Paroxysmal Kinesigenic Dyskinesia: First Molecularly Confirmed Case from Africa.

Tremor and other hyperkinetic movements (New York, N.Y.)
2020

[Identification of two novel PRRT2 gene variants in two children with paroxysmal kinesigenic dyskinesia].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2020

Activity-dependent cleavage of dyskinesia-related proline-rich transmembrane protein 2 (PRRT2) by calpain in mouse primary cortical neurons.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2019

PRRT2 gene variant in a child with dysmorphic features, congenital microcephaly, and severe epileptic seizures: genotype-phenotype correlation?

Italian journal of pediatrics
2020

PRRT2 frameshift mutation reduces its mRNA stability resulting loss of function in paroxysmal kinesigenic dyskinesia.

Biochemical and biophysical research communications
2019

Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.

BMC pediatrics
2019

Paroxysmal Kinesigenic Dyskinesia Symptoms Markedly Reduced with Parenteral Vitamins and Minerals: A Case Report.

The Permanente journal
2020

Primary familial brain calcification presenting as paroxysmal kinesigenic dyskinesia: Genetic and functional analyses.

Neuroscience letters
2019

Genetic and clinical analyses of spinocerebellar ataxia type 8 in mainland China.

Journal of neurology
2019

Tics in Paroxysmal Kinesigenic Dyskinesia.

Movement disorders clinical practice
2019

Paroxysmal Movement Disorders: Recent Advances.

Current neurology and neuroscience reports
2019

Phenotypic Diversity of Myoclonus Epilepsy Associated with Ragged-red Fibers with an 8344A>G mtDNA Mutation.

Internal medicine (Tokyo, Japan)
2019

PRRT2 mutations in Japanese patients with benign infantile epilepsy and paroxysmal kinesigenic dyskinesia.

Seizure
2019

PRRT2 missense mutations cluster near C-terminus and frequently lead to protein mislocalization.

Epilepsia
2019

Paroxysmal movement disorders: Recent advances and proposal of a classification system.

Parkinsonism &amp; related disorders
2019

Paroxysmal and cognitive phenotypes in Prrt2 mutant mice.

Genes, brain, and behavior
2019

The experience of the multidisciplinary team in epilepsy management from a resource-limited country.

Epilepsia open
2019

Associations between neuroanatomical abnormality and motor symptoms in paroxysmal kinesigenic dyskinesia.

Parkinsonism &amp; related disorders
2018

Paroxysmal Dyskinesias in a PRRT2 Mutation Carrier.

Tremor and other hyperkinetic movements (New York, N.Y.)
2019

Paroxysmal Kinesigenic Dyskinesia Presented Following Concussion.

Journal of movement disorders
2019

Acute-Onset Ataxia and Transient Cerebellar Diffusion Restriction Associated with a PRRT2 Mutation.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
2018

[Clinical characteristics and genetic features of benign infantile epilepsy with PRRT2 mutation].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2018

Aberrant Sensory Gating of the Primary Somatosensory Cortex Contributes to the Motor Circuit Dysfunction in Paroxysmal Kinesigenic Dyskinesia.

Frontiers in neurology
2019

PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by influencing synaptic function in the primary motor cortex of rats.

Neurobiology of disease
2018

16p11.2 deletion in patients with paroxysmal kinesigenic dyskinesia but without intellectual disability.

Brain and behavior
2018

The study of exercise tests in paroxysmal kinesigenic dyskinesia.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2018

Paroxysmal Dyskinesia in Children: from Genes to the Clinic.

Journal of clinical neurology (Seoul, Korea)
2018

[Paroxysmal dyskinesias - disorder categories, their causes and treatment].

Wiadomosci lekarskie (Warsaw, Poland : 1960)
2019

PRRT2-related phenotypes in patients with a 16p11.2 deletion.

European journal of medical genetics
2018

A PRRT2 variant in a Chinese family with paroxysmal kinesigenic dyskinesia and benign familial infantile seizures results in loss of interaction with STX1B.

Epilepsia
2018

Falling After Starting Running in a Case of Myoclonus Epilepsy Associated with Ragged-red Fibers with a 8344A>G mtDNA Mutation.

Internal medicine (Tokyo, Japan)
2018

Quick Flicks: Association of Paroxysmal Kinesigenic Dyskinesia and Tics.

Movement disorders clinical practice
2018

Misdiagnosed atypical paroxysmal kinesigenic dyskinesia: a case report.

Neuropsychiatric disease and treatment
2018

Phenotypes, genotypes, and the management of paroxysmal movement disorders.

Developmental medicine and child neurology
2018

PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity.

Brain : a journal of neurology
2018

CHRNA4 variant causes paroxysmal kinesigenic dyskinesia and genetic epilepsy with febrile seizures plus?

Seizure
2018

Paroxysmal Kinesigenic Dyskinesia.

Indian pediatrics
2018

Myotonia Congenita Can Be Mistaken as Paroxysmal Kinesigenic Dyskinesia.

Journal of movement disorders
2018

Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients.

Movement disorders : official journal of the Movement Disorder Society
2018

Familial paroxysmal kinesigenic dyskinesia is associated with mutations in the KCNA1 gene.

Human molecular genetics
2017

Transcallosal conduction in paroxysmal kinesigenic dyskinesia.

Somatosensory &amp; motor research
2018

PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.

The International journal of neuroscience
2018

A novel PRRT2 pathogenic variant in a family with paroxysmal kinesigenic dyskinesia and benign familial infantile seizures.

Cold Spring Harbor molecular case studies
2018

PRRT2-dependent dyskinesia: cerebellar, paroxysmal and persistent.

Cell research
2017

[Clinical manifestations and genetic diagnosis of paroxysmal kinesigenic dyskinesia].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2018

PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum.

Cell research
2017

Thalamotomy for paroxysmal kinesigenic dyskinesias in a multiplex family.

European journal of neurology
2017

A case of paroxysmal kinesigenic dyskinesia which exhibited the phenotype of anxiety disorder.

Neuropsychiatric disease and treatment
2017

Depression, anxiety, and quality of life in paroxysmal kinesigenic dyskinesia patients.

Chinese medical journal
Ver todos os 253 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Discinesia paroxística cinesigênica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Discinesia paroxística cinesigênica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Case of Atypical Presentation of Paroxysmal Movement Disorder, Contributed to PRRT2 Gene Variant.
    Journal of child neurology· 2026· PMID 41662224mais citado
  2. Heterozygous Loss-of-Function Variants of KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia.
    Movement disorders : official journal of the Movement Disorder Society· 2026· PMID 41772895mais citado
  3. Motor-planning cerebello-cerebral network alterations in PRRT2-related paroxysmal kinesigenic dyskinesia.
    Parkinsonism &amp; related disorders· 2026· PMID 41564648mais citado
  4. Clinical and Genetic Characteristics of Paroxysmal Kinesigenic Dyskinesia: A Single-Center Study and Literature Review.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology· 2026· PMID 41553070mais citado
  5. Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion: A Case Report.
    Case reports in neurology· 2025· PMID 41322066mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98809(Orphanet)
  2. MONDO:0044202(MONDO)
  3. GARD:8721(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q3042113(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Discinesia paroxística cinesigênica

ORPHA:98809 · MONDO:0044202
🇧🇷 Brasil SUS
Triagem
qPCR para deleção de SMN1 em sangue seco
PNTN
Fase 5
Incidência BR
1:10.000
Geral
Prevalência
1-9 / 1 000 000
Herança
Autosomal dominant, Not applicable
CID-10
G24.8 · Outras distonias
CID-11
Ensaios
2 ativos
Início
Adolescent, Adult, Childhood, Infancy
Prevalência
0.6 (Worldwide)
MedGen
UMLS
C1868682
Repurposing
4 candidatos
istradefyllineadenosine receptor antagonist
methanthelineacetylcholine receptor antagonist
tiapridedopamine receptor antagonist
+1 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades